References
- Chiong W. Diagnosing and defining disease. JAMA 2001; 285: 89–90
- Esch E PV, Muir C S, Nectous J, MacFarlane G, Maisonneuve P, Bharucha H, et al. Temporal change in diagnostic criteria as a cause of the increase in malignant melanoma is unlikely. Int J Cancer 1991; 47: 483–9
- Edman R L, Klaus S N. Is routine screening for melanoma a benign practice?. JAMA 2000; 284: 883–5
- Piepkorn M, Odland P B. Quality of care in the diagnosis of melanoma and related melanocytic lesions. Arch Dermatol 1997; 113: 1393–6
- Corona R, Mele A, Amini M, Rosa G, Coppola G, Piccardi P, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 1996; 14: 1218–23
- Ackerman A B. Discordance among expert pathologists in diagnosis of melanocytic neoplasms. Hum Pathol 1996; 27: 1115–6
- Farmer E R, Gonin R, Hanna M P. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 1996; 27: 528–31
- U.S. Preventive Service Task Force. Guide to clinical preventive services. 2nd ed. Williams & Wilkins, Baltimore 1996
- , http://www.ahrq.gov/clinic/prevenix.htm
- Kent A. Raising awareness or spreading fear?. BMJ 2000; 321: 247
- Bunker J P, Houghton J, Baum M. Putting the risk of breast cancer in perspective. BMJ 1998; 317: 1307–9
- Harris J R, Lippman M E, Veronesi U, Willet W. Breast cancer. N Engl J Med 1992; 327: 319–28
- Shapiro S, Coleman E A, Broeders M, Codd M, Koning H, Fracheboud J, et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. Int J Epidemiol 1998; 27: 735–42
- Wright C J, Mueller C B. Screening mammography and public health policy: the need for perspective. Lancet 1995; 346: 29–32
- Elmore J G, Wells C K, Lee C H, Howard D H, Feinstein A R. Variability in radiologists' interpretations of mammograms. N Engl J Med 1994; 331: 1493–9
- Mushlin A I, Kouides R W, Shapiro D E. Estimating the accuracy of screening mammography: a meta-analysis. Am J Prev Med 1998; 14: 143–53
- Silverstein M J, Lagios M. Benefits of irradiation for DCIS: a Pyrrhic victory. Lancet 2000; 355: 510–1
- Ernster V, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 2000; 160: 953–8
- Elmore J G, Barton M B, Moceri V M, Polk S, Arena P J, Fletcher S W. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998; 338: 1089–96
- Smith S. The ethics of ignorance. J Med Ethics 1992; 18: 117–8; 134
- Wilson R M. Screening for breast and cervical cancer as a common cause for litigation. BMJ 2000; 320: 1352–3
- Irvine D. The changing relationship between the public and the medical profession. J R Soc Med 2001; 94: 162–9